Therapeutic Plasma Exchange and Changes in Calcium, Phosphate, Parathyroid Hormone, and Fibroblast Growth Factor-23
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgaf400 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Sami SeungMi Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of California San Diego, 9452 Medical Center Dr, L3E206, La Jolla, CA 92037, USA. Hauptthemen laut MEDLINE: Parathyroid Hormone, Fibroblast Growth Factors, Calcium, Phosphates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, University of California San Diego, National Institute of Diabetes Digestive and Kidney Diseases.
Abstract (Originalsprache)
Context
Therapeutic plasma exchange (TPE) removes plasma proteins and other unwanted substances, causing nonspecific alterations of plasma components. A previous study showed an approximately 70% reduction in vitamin D metabolites following a single TPE treatment, prompting further investigation into TPE's effects on vitamin D regulators and metabolites: calcium, phosphate, parathyroid hormone (PTH), and fibroblast growth factor-23 (FGF-23).
Objective
This study examined changes in plasma and effluent levels of total calcium, phosphate, PTH, and FGF-23 in individuals undergoing TPE.
Methods
Measurements were taken immediately before, immediately after, and at follow-up. Paired t tests compared the percentage changes in metabolites from pre- to post-TPE.
Results
Study participants (N = 42) had a mean age of 55 ± 16 years, 28 (67%) were female, and 32 (76%) were White. TPE led to acute changes in calcium (−9%; 95% CI, −11% to −8%), phosphate (−14%; −18% to −11%), and FGF-23 (−12%; −18% to −6%) concentrations. In contrast, PTH levels increased (91%; 63%-119%) from baseline to post-TPE. While most metabolites returned to baseline by the follow-up visit (median 4 [interquartile range, 3-7] days), nearly 25% of patients experienced persistent asymptomatic hypocalcemia. This persistent calcium deficit was not fully corrected by continuous intravenous calcium gluconate infusions administered during the study, nor by the endogenously increased PTH levels.
Conclusion
These findings underscore the need for improved care protocols and vigilant monitoring of mineral metabolism in TPE patients, especially those receiving long-term treatment. Further research is warranted to understand the enduring effects of TPE on mineral metabolism and develop strategies to prevent complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of California San Diego, 9452 Medical Center Dr, L3E206, La Jolla, CA 92037, USA.
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Department of Laboratory Medicine and Pathology and Medicine and the Kidney Research Institute, University of Washington, Seattle, WA 98195, USA.
- Division of Nephrology-Hypertension, University of California San Diego, San Diego, CA 92037, USA.
- Nephrology Section, Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, USA.
ORCID-Profile: Sami SeungMi Jin, Charles Ginsberg
Förderung
- NIDDK NIH HHS
- University of California San Diego
- National Institute of Diabetes Digestive and Kidney Diseases
- O'Brien Center for Acute Kidney Injury Research
- O’Brien Center for Acute Kidney Injury Research
Zitieren
APA
Jin, S. S., Dugar, A., Hoofnagle, A. N., Sanchez, A. P., Ward, D. M., Ix, J. H., & Ginsberg, C. (2026). Therapeutic Plasma Exchange and Changes in Calcium, Phosphate, Parathyroid Hormone, and Fibroblast Growth Factor-23. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf400
Vancouver
Jin SS, Dugar A, Hoofnagle AN, Sanchez AP, Ward DM, Ix JH, et al. Therapeutic Plasma Exchange and Changes in Calcium, Phosphate, Parathyroid Hormone, and Fibroblast Growth Factor-23. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf400
BibTeX
@article{Jin2026,
author = {Jin, Sami SeungMi and Dugar, Anushree and Hoofnagle, Andrew N and Sanchez, Amber P and Ward, David M and Ix, Joachim H and Ginsberg, Charles},
title = {Therapeutic Plasma Exchange and Changes in Calcium, Phosphate, Parathyroid Hormone, and Fibroblast Growth Factor-23},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgaf400}
}
EUVIMED